BlueCrest Capital Management’s MiMedx Group MDXG Stock Holding History

BlueCrest Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-161,891	Closed	-$1M	–	1195
2018 Q3	$1M	Buy	161,891 +26,415	+19%	+$119K	0.03%	447
2018 Q2	$866K	Buy	+135,476	New	+$964K	0.02%	583
2018 Q1	–	Sell	-10,017	Closed	-$126K	–	1577
2017 Q4	$126K	Buy	+10,017	New	+$122K	﹤0.01%	750

Other funds holding MDXG

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

TIM

Thompson Investment Management Madison, Wisconsin $872M AUM 35.59% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

WMC

Westwood Management Corporation Chicago, Illinois $270M AUM 54.59% 1-Year Est. Return

PAM

Pegasus Asset Management Montebello, New York $313M AUM 24.74% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

BlueCrest Capital Management's MDXG Position: Q4 2018 in Review

BlueCrest Capital Management sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 161,891 shares — an estimated $1M sold.

BlueCrest Capital Management first reported a position in MDXG in Q4 2017 and held it in 3 quarters. The position peaked at $1M in Q3 2018. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

BlueCrest Capital Management reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
BlueCrest Capital Management sold 161,891 MiMedx Group shares in Q4 2018, an estimated $1M.
BlueCrest Capital Management first reported a position in MiMedx Group in Q4 2017 and held it in 3 quarters.
BlueCrest Capital Management's MiMedx Group position peaked at $1M in Q3 2018.
38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.